[1]
N. Albaser, A. Al-Ghani, and A. . Thabit, “In vitro Comparative Quality Assessment of Four Brands of Moxifloxacin 400 mg Tablets Marketed in Yemen”, RUJMS, vol. 5, no. 1, Jun. 2021.